Effect of Oral Capsule– vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2017-11-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/jama.2017.17077PMID 29183074PMCID PMC5820695
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Faculty Opinions recommendation of Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.

  2018cited by this paper
• Methods and Reporting Studies Assessing Fecal Microbiota Transplantation

  2017cited by this paper
• Successful Resolution of Recurrent Clostridium difficile Infection using Freeze-Dried, Encapsulated Fecal Microbiota; Pragmatic Cohort Study

  2017cited by this paper
• Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

  2017cited by this paper
• Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.

  2017cited by this paper
• Successful Resolution of Recurrent Clostridium difficile Infection Using Freeze-Dried, Encapsulated Fecal Microbiota: Pragmatic Cohort Study

  2017cited by this paper
• Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease

  2016cited by this paper
• Efficacy and Safety of RBX2660 for the Prevention of Recurrent Clostridium difficile Infection: Results of the PUNCH CD 2 Trial

  2016cited by this paper
• Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection

  2016cited by this paper
• Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.

  2016cited by this paper
• Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.

  2016cited by this paper
• Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook.

  2015cited by this paper
• Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection

  2015cited by this paper
• Kraken: ultrafast metagenomic sequence classification using exact alignments

  2014cited by this paper
• Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis.

  2014cited by this paper
• Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study.

  2014cited by this paper
• Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: An Economic Evaluation

  2014cited by this paper
• Fecal Microbiota Transplantation for the Treatment of Clostridium difficile Infection: A Systematic Review

  2014cited by this paper
• Fecal Microbiota Transplant for Treatment of Clostridium difficile Infection in Immunocompromised Patients

  2014cited by this paper
• Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection.

  2014cited by this paper
• Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.

  2014cited by this paper
• Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system.

  2013cited by this paper
• Fecal microbiota transplantation and donor standardization.

  2013cited by this paper
• Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis

  2013cited by this paper
• Duodenal infusion of donor feces for recurrent Clostridium difficile.

  2013cited by this paper
• Image of the month: “butterfly” effect, or mirror image, caused by a coiled esophageal manometry catheter.

  2013cited by this paper
• Defining the Vulnerable Period for Re-Establishment of Clostridium difficile Colonization after Treatment of C. difficile Infection with Oral Vancomycin or Metronidazole

  2013cited by this paper
• Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections

  2013cited by this paper
• EMPeror: a tool for visualizing high-throughput microbial community data

  2013cited by this paper
• Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection.

  2012cited by this paper
• Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection.

  2012cited by this paper
• Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis

  2012cited by this paper
• Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection in 26 Patients: Methodology and Results

  2012cited by this paper
• Systematic review: faecal transplantation for the treatment of Clostridium difficile‐associated disease

  2012cited by this paper
• Standardized Frozen Preparation for Transplantation of Fecal Microbiota for Recurrent Clostridium difficile Infection

  2012cited by this paper
• Toward an Understanding of Changes in Diversity Associated with Fecal Microbiome Transplantation Based on 16S rRNA Gene Deep Sequencing

  2012cited by this paper
• Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection.

  2011cited by this paper
• Fidaxomicin versus vancomycin for Clostridium difficile infection.

  2011cited by this paper
• Treating Clostridium difficile infection with fecal microbiota transplantation.

  2011cited by this paper
• Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea

  2010cited by this paper
• Changes in the Composition of the Human Fecal Microbiome After Bacteriotherapy for Recurrent Clostridium difficile-associated Diarrhea

  2009cited by this paper
• Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study.

  2009cited by this paper
• Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea.

  2008cited by this paper
• Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile.

  2002cited by this paper

• Diagnostic challenges and treatment approaches for Clostridioides difficile infection in IBD patients

  2026cites this paper
• Fecal microbiota transplantation plus immunotherapy in metastatic renal cell carcinoma: the phase 1 PERFORM trial.

  2026cites this paper
• Gut microbiome and obesity care: Bridging dietary, surgical, and pharmacological interventions.

  2026cites this paper
• Oral immunization with engineered probiotics expressing tcdB protects mice against Clostridioides difficile infection.

  2026cites this paper
• Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial.

  2026cites this paper
• Strain-level genetic heterogeneity and colonization dynamics drive microbiome therapeutic efficacy.

  2026cites this paper
• Methodological insights into fecal microbiota transplantation: Dissecting key approaches for success

  2026cites this paper
• Fecal Microbiota Transplantation in 2025: Two Steps Forward, One Step Back

  2026influential citation
• Narrative review on microbiota and sepsis: the host's betrayal?

  2025cites this paper
• Advances in the Study of Metabolic Interactions between Bile Acids and Gut Microbes and Their Regulatory Role in Disease Development

  2025cites this paper
• Comparative effectiveness of different therapies for Clostridioides difficile infection in adults: a systematic review and network meta-analysis of randomized controlled trials

  2025cites this paper
• Assessing live microbial therapeutic transmission

  2025cites this paper
• A Review of Recent Advances in Fecal Microbiota Transplantation for the Treatment of Hepatic Encephalopathy

  2025cites this paper
• OVERVIEW OF CLINICAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CLOSTRIDIODIOIDES DIFFICILE-ASSOCIATED INFECTION

  2025cites this paper
• Prevention of recurrent Clostridioides difficile infection by fecal microbiota, live-jslm (REBYOTA®) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trial

  2025cites this paper
• Microbiota transplant therapy in inflammatory bowel disease: advances and mechanistic insights

  2025cites this paper
• Fecal microbiota transplantation for patients with ulcerative colitis: a systematic review and meta-analysis of randomized control trials

  2025cites this paper
• Intestinal Microbiota Modulation by Fecal Microbiota Transplantation in Nonalcoholic Fatty Liver Disease

  2025cites this paper
• Risk Factors for Antibiotic Exposure Post–Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection: A Prospective Multicenter Observational Study

  2025cites this paper
• Operationalizing Team Science at the Academic Cancer Center Network to Unveil the Structure and Function of the Gut Microbiome

  2025cites this paper
• Crosstalk Between Microbiome and Ferroptosis in Diseases: From Mechanism to Therapy

  2025cites this paper
• From gut microbial ecology to lipid homeostasis: Decoding the role of gut microbiota in dyslipidemia pathogenesis and intervention

  2025cites this paper
• Gut microbiota and nutritional interventions in alcohol-associated liver disease: Mechanisms and therapeutic advances.

  2025cites this paper
• Long-term safety of fecal microbiota transplantation in Chinese children from 2013 to 2023: a single-center retrospective study

  2025influential citation
• Analysis of influencing factors of washed microbiota transplantation in treating patients with metabolic syndrome

  2025cites this paper
• Modulating the microbiome in chronic liver diseases – current evidence on the role of fecal microbiota transplantation

  2025cites this paper
• Diagnosis and Management of C. difficile.

  2025cites this paper
• Fecal microbiome transplantation in the treatment of chronic enteropathies.

  2025cites this paper
• Fecal microbiota transplantation in allergic diseases

  2025cites this paper
• Autologous fecal microbiota capsules are safe and potentially preserve beta-cell function in individuals with type 1 diabetes

  2025cites this paper
• Advancements in the Pathogenesis, Diagnosis, and Therapeutic Implications of Intestinal Bacteria

  2025cites this paper
• Review Article: Fecal Microbiota Transplantation in Melanoma: Mechanisms-Mediated Enhancement of Anti-Tumor Immunotherapy.

  2025cites this paper
• Five-Day Treatment with B. licheniformis Along with Classical Vancomycin Treatment Was Effective in Preserving Gut Microbiota in Patients with Clostridioides difficile Infection

  2025cites this paper
• Effects of lyophilised faecal filtrate compared with lyophilised donor stool on Clostridioides difficile recurrence: a multicentre, randomised, double-blinded, non-inferiority trial.

  2025cites this paper
• Pilot Clinical Trial of Fecal Microbiota Transplantation for Constipation in Parkinson's Disease

  2025cites this paper
• Prospective analysis of biomarkers associated with successful faecal microbiota transplantation in recurrent Clostridioides difficile Infection.

  2025cites this paper
• Validation methods for encapsulated faecal microbiota transplantation: a scoping review

  2025cites this paper
• Fecal microbiota transplantation to reduce immune activation in ART-treated people with HIV with low CD4/CD8 ratio: protocol for the single-blind, randomized, placebo-controlled Gutsy study (CIHR/CTN PT038)

  2025cites this paper
• Fecal Microbiota Transplantation Versus Vancomycin for Primary Clostridioides difficile Infection : A Randomized Controlled Trial.

  2025cites this paper
• A Randomized Controlled Trial of Efficacy and Safety of Fecal Microbiota Transplant for Preventing Recurrent Clostridioides difficile Infection: The Failure of a Procedure, not of a Therapy.

  2025cites this paper
• Gut Microbial Targets in Inflammatory Bowel Disease: Current Position and Future Developments

  2025influential citation
• Fecal microbiota transplantation: present and future

  2025cites this paper
• Translational strategies for oral delivery of faecal microbiota transplantation

  2025cites this paper
• Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship.

  2025cites this paper
• Fecal microbiota transplantation for hypertension: an exploratory, multicenter, randomized, blinded, placebo-controlled trial

  2025cites this paper
• Fecal microbiota transplantation as a therapeutic modality for recurrent Clostridioides difficile infection: reviewing efficacy, safety, mechanisms of action, and outcomes

  2025influential citation
• Factors Associated with FMT Failure in Clostridioides difficile Infection and Age-Related Considerations: A Review

  2025cites this paper
• Fecal microbiota transplantation restores gut microbiota diversity in children with active Crohn’s disease: a prospective trial

  2025cites this paper
• The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development

  2025cites this paper
• Safety and efficacy of fecal microbiota transplantation in the treatment of Parkinson’s disease: a systematic review of clinical trials

  2025cites this paper
• Live biotherapeutic product exhibits similar efficacy and superior engraftment to same donor fecal microbiota transplant for recurrent Clostridioides difficile infection

  2025cites this paper
• Advances in capsule-based fecal microbiota transplantation: clinical applications and innovations

  2025cites this paper
• In vitro validation concept for lyophilized fecal microbiota products with a focus on bacterial viability

  2025cites this paper
• Management of Recurrent Clostridioides difficile Infection (rCDI): A Systematic Literature Review to Assess the Feasibility of Indirect Treatment Comparison (ITC)

  2025cites this paper
• Untargeted Metabolomics Identifies Faecal Filtrate-Derived Metabolites That Disrupt Clostridioides difficile Metabolism and Confer Gut Barrier Cytoprotection

  2025cites this paper
• Gut microbial metabolites in cancer immunomodulation

  2025cites this paper
• Three-dimensionally printed navigational template technology for lung biopsy: a noninferiority, randomized trial

  2025cites this paper
• Impact of Fecal Microbiota Transplant Formulations, Storage Conditions, and Duration on Bacterial Viability, Functionality, and Clinical Outcomes in Patients with Recurrent Clostridioides difficile Infection

  2025cites this paper
• Role of the microbiota–gut–lung axis in the pathogenesis of pulmonary disease in children and novel therapeutic strategies

  2025cites this paper
• A randomized controlled trial of efficacy and safety of Fecal Microbiota Transplant for preventing recurrent Clostridioides difficile infection.

  2024cites this paper
• Oral Fecal Microbiota Transplantation in Dogs with Tylosin-Responsive Enteropathy—A Proof-of-Concept Study

  2024cites this paper
• Fecal microbiota spores, live-brpk (VOWST™/VOS) for prevention of recurrent Clostridioides difficile infection.

  2024cites this paper
• Causal role of the gut microbiome in certain human diseases: a narrative review

  2024cites this paper
• Design of probiotic delivery systems and therapeutic effects on target sites in the body.

  2024cites this paper
• The Role of Fecal Microbiota Transplantation (FMT) in the Management of Metabolic Diseases in Humans: A Narrative Review

  2024cites this paper
• Faecal microbiota transplantation associated adverse events

  2024cites this paper
• Effect of intestinal microbiota transplantation on chronic hepatitis B virus infection associated liver disease

  2024cites this paper
• Clinical Guidelines for Fecal Microbiota Transplantation in Companion Animals

  2024cites this paper
• Gut Microbiota Disruption in Hematologic Cancer Therapy: Molecular Insights and Implications for Treatment Efficacy

  2024cites this paper
• Beyond Antibiotics: Novel Approaches in the Treatment of Recurrent Clostridioides difficile Infection

  2024cites this paper
• Human intestinal microbiome: Role in health and disease

  2024cites this paper
• Assessing the Therapeutic Potential of Fecal Microbiota Transplantation in Steatotic Liver Disease: Current Insights and Future Pathways

  2024cites this paper
• Washed Microbiota Transplantation Is Associated With Improved Lipid Profiles: Long-Term Efficacy and Safety in an Observational Cohort From South China

  2024cites this paper
• Human diseases treatment via enema fecal microbiota transplantation. Methodological recommendations

  2024cites this paper
• Human Gut Microbiota in Cardiovascular Disease.

  2024cites this paper
• Fecal microbiota transplantation: current challenges and future landscapes

  2024cites this paper
• Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis

  2024cites this paper
• A Comparison of Currently Available and Investigational Fecal Microbiota Transplant Products for Recurrent Clostridioides difficile Infection

  2024cites this paper
• Fecal microbiota transplantation in autoimmune diseases - An extensive paper on a pathogenetic therapy.

  2024cites this paper
• Unraveling the Microbiome–Human Body Axis: A Comprehensive Examination of Therapeutic Strategies, Interactions and Implications

  2024cites this paper
• Microbiota therapeutics for inflammatory bowel disease: the way forward.

  2024cites this paper
• Awareness and acceptability of gut microbiome transfer

  2024cites this paper
• ‘Does this fecal microbiota transplant work?’ Quality assurance of capsule based fecal microbiota transplant production

  2024cites this paper
• Effects of scaffolding and inner speech on learning motivation, flexible thinking and academic achievement in the technology-enhanced learning environment

  2024cites this paper
• Microbiome and In Vitro Gut Models

  2024cites this paper
• Microbiota-Based Live Biotherapeutic Products for Clostridioides Difficile Infection- The Devil is in the Details

  2024cites this paper
• Clostridioides difficile Infection: Diagnosis and Treatment Challenges

  2024cites this paper
• Exploring the Relationship between Liver Disease, Bacterial Translocation, and Dysbiosis: Unveiling the Gut-Liver Axis

  2024cites this paper
• Fecal bacteria-free filtrate transplantation is proved as an effective way for the recovery of radiation-induced individuals in mice

  2024cites this paper
• Gut–Liver Axis as a Therapeutic Target for Drug-Induced Liver Injury

  2024cites this paper
• The Use of Fecal Microbiota Transplant in Overcoming and Modulating Resistance to Anti-PD-1 Therapy in Patients with Skin Cancer

  2024cites this paper
• Colonic Delivery of Aqueous Suspensions Using 3D Printed Capsules

  2024cites this paper
• Escape Velocity - The Launch of Microbiome Therapies.

  2024cites this paper
• Quality of life among older patients receiving faecal microbiota transplant for Clostridioides difficile infection.

  2024cites this paper
• Factors of faecal microbiota transplantation applied to cancer management

  2024cites this paper
• Dissecting mechanisms of fecal microbiota transplantation efficacy in disease.

  2024cites this paper
• Review article: The epidemiology and management of Clostridioides difficile infection—A clinical update

  2024cites this paper
• Lyophilized fecal microbiome transfer for primary Clostridioides difficile infection: a multicenter randomized controlled trial (DONATE Study)

  2024cites this paper
• Comparison of the use of a spiral nasojejunal tube and transendoscopic enteral tubing in washed microbiota transplantation via the mid-gut route

  2024cites this paper
• Gut Microbiota and Autoimmune Diseases: Mechanisms, Treatment, Challenges, and Future Recommendations

  2024cites this paper